BAAM
CVS icon

Baker Avenue Asset Management’s CVS Health CVS Stock Holding History

Baker Avenue Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$909K Buy
8,782
+1,279
+17% +$114K 0.02% 322
2026
Q1 		$539K Buy
7,503
+1,228
+20% +$94.6K 0.01% 403
2025
Q4 		$498K Buy
6,275
+351
+6% +$27.7K 0.01% 379
2025
Q3 		$447K Buy
5,924
+2,206
+59% +$151K 0.01% 376
2025
Q2 		$256K Buy
+3,718
New +$244K 0.01% 421
2023
Q4 		– Sell
-722
Closed -$50.4K – 622
2023
Q3 		$50.4K Buy
722
+132
+22% +$9.35K ﹤0.01% 520
2023
Q2 		$40.8K Buy
590
+562
+2,007% +$40K ﹤0.01% 551
2023
Q1 		$2.08K Sell
28
-277
-91% -$23.2K ﹤0.01% 982
2022
Q4 		$28.4K Buy
+305
New +$29.4K ﹤0.01% 564

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Baker Avenue Asset Management's CVS Position: Q2 2026 in Review

Baker Avenue Asset Management increased its CVS Health (CVS) stake by 17% in Q2 2026, buying an estimated $114K and bringing the position to 8,782 shares worth $909K. The position accounts for 0.02% of the portfolio, ranked #322.

Baker Avenue Asset Management first reported a position in CVS in Q4 2022 and has held it in 9 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Baker Avenue Asset Management held 8,782 shares of CVS Health worth $909K as of Q2 2026.
  • Baker Avenue Asset Management bought 1,279 CVS Health shares in Q2 2026, an estimated $114K.
  • CVS Health made up 0.02% of Baker Avenue Asset Management's portfolio in Q2 2026, its #322 holding.
  • Baker Avenue Asset Management first reported a position in CVS Health in Q4 2022 and has held it in 9 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.